Td Asset Management Inc Crinetics Pharmaceuticals, Inc. Transaction History

Td Asset Management Inc

$102 Billion
Q1 2025

A detailed history of Td Asset Management Inc transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 174,694 shares of CRNX stock, worth $5.88 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

174,694

Previous 229,004 23.72%

Holding current value

$5.88 Million

Previous $11.7 Million 49.96%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 07, 2025	SELL	$32.3 - $53.15 $1.75 Million - $2.89 Million	-54,310 Reduced 23.72%	174,694 $5.86 Million
Q4 2024 Feb 11, 2025	BUY	$50.66 - $60.69 $956,562 - $1.15 Million	18,882 Added 8.99%	229,004 $11.7 Million
Q3 2024 Nov 01, 2024	BUY	$43.83 - $54.98 $224,584 - $281,717	5,124 Added 2.5%	210,122 $10.7 Million
Q2 2024 Aug 02, 2024	SELL	$42.12 - $51.91 $1.27 Million - $1.57 Million	-30,200 Reduced 12.84%	204,998 $9.18 Million
Q1 2024 May 08, 2024	BUY	$34.76 - $46.81 $2.04 Million - $2.75 Million	58,772 Added 33.31%	235,198 $11 Million
Q4 2023 Feb 12, 2024	BUY	$25.62 - $37.07 $947,940 - $1.37 Million	37,000 Added 26.54%	176,426 $6.28 Million
Q3 2023 Oct 27, 2023	BUY	$15.97 - $30.59 $1.29 Million - $2.46 Million	80,526 Added 136.72%	139,426 $4.15 Million
Q2 2023 Aug 09, 2023	BUY	$15.73 - $23.6 $492,349 - $738,680	31,300 Added 113.41%	58,900 $1.06 Million
Q1 2023 May 10, 2023	BUY	$15.31 - $21.1 $422,556 - $582,360	27,600 New	27,600 $443,000
Q3 2019 Nov 07, 2019	SELL	$14.91 - $25.01 $125,527 - $210,559	-8,419 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$21.48 - $27.71 $180,840 - $233,290	8,419 New	8,419 $210,000
Q1 2019 May 08, 2019	SELL	$21.07 - $29.31 $202,672 - $281,932	-9,619 Closed	0 $0
Q4 2018 Feb 01, 2019	SELL	$22.4 - $35.39 $29,119 - $46,007	-1,300 Reduced 11.91%	9,619 $288,000
Q3 2018 Nov 01, 2018	BUY	$22.66 - $36.8 $247,424 - $401,819	10,919 New	10,919 $313,000

Others Institutions Holding CRNX

# of Institutions

246

Shares Held

82.1M

Call Options Held

26.1K

Put Options Held

11.8K

View Full List

About Crinetics Pharmaceuticals, Inc.

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $1.81B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

More about CRNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Crinetics Pharmaceuticals, Inc. Transaction History